Jeffrey S. Morris

13.7k total citations · 2 hit papers
196 papers, 8.9k citations indexed

About

Jeffrey S. Morris is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jeffrey S. Morris has authored 196 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 39 papers in Oncology and 35 papers in Cancer Research. Recurrent topics in Jeffrey S. Morris's work include Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Gene expression and cancer classification (23 papers) and Advanced Proteomics Techniques and Applications (21 papers). Jeffrey S. Morris is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Gene expression and cancer classification (23 papers) and Advanced Proteomics Techniques and Applications (21 papers). Jeffrey S. Morris collaborates with scholars based in United States, United Kingdom and Egypt. Jeffrey S. Morris's co-authors include Keith Baggerly, Kevin R. Coombes, Raymond J. Carroll, Asif Rashid, James L. Abbruzzese, Jaffer A. Ajani, Stanley R. Hamilton, Li Deng, Imad Shureiqi and C. Marcelo Aldaz and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Jeffrey S. Morris

190 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes

2022 218 citations Jeffrey S. Morris et al. profile →
Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios

2021 173 citations Jeffrey S. Morris et al. profile →

Peers

Countries citing papers authored by Jeffrey S. Morris

Since Specialization

Citations

This map shows the geographic impact of Jeffrey S. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Morris more than expected).

Fields of papers citing papers by Jeffrey S. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Morris. The network helps show where Jeffrey S. Morris may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Morris. A scholar is included among the top collaborators of Jeffrey S. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Morris. Jeffrey S. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma 2024 ·SHILAP Revista de lepidopterología ·(unknown), Betül Gök Yavuz, Yehia I. Mohamed, Sunyoung S. Lee, James C. Yao, (unknown), (unknown), Lianchun Xiao, (unknown), Jeffrey S. Morris, Rikita Hatia, Manal M. Hassan, Dan G. Duda, Maria Diab, (unknown), Ahmed Nassar, Hesham M. Amin, Ahmed O. Kaseb	3
2	Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis 2020 ·Cancer Research ·Yvonne A. Evrard, Anuj Srivastava, Jelena Randjelović, James H. Doroshow, (unknown), Jeffrey S. Morris, Jeffrey H. Chuang	30
3	Comparison of extraocular and intraocular pressure transducers for measurement of transient intraocular pressure fluctuations using continuous wireless telemetry 2020 ·Scientific Reports ·Jessica V. Jasien, (unknown), (unknown), Lindsay A. Rhodes, Brian C. Samuels, Christopher A. Girkin, Jeffrey S. Morris, J. Crawford Downs	5
4	An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses 2019 ·Cancer Immunology Research ·Ismail M. Meraz, Mourad Majidi, Feng Meng, (unknown), Min Jin Ha, Shinya Neri, Bingliang Fang, Steven H. Lin, Peggy T. Tinkey, Elizabeth J. Shpall, Jeffrey S. Morris, Jack A. Roth	108
5	Pleiotropic Effects of PPARD Accelerate Colorectal Tumorigenesis, Progression, and Invasion 2019 ·Cancer Research ·Yi Liu, Yasunori Deguchi, Rui Tian, Daoyan Wei, Ling Wu, Weidong Chen, Weiguo Xu, Min Xu, Fuyao Liu, Shen Gao, Jonathan C. Jaoude, (unknown), Micheline J. Moussalli, Mihai Gagea, Jeffrey S. Morris, Russell R. Broaddus, Xiangsheng Zuo, Imad Shureiqi	45
6	Modeling of Patient-Derived Xenografts in Colorectal Cancer 2017 ·Molecular Cancer Therapeutics ·Αναστασία Κατσιαμπούρα, Kanwal Raghav, Zhi-Qin Jiang, David G. Menter, Andreas Varkaris, Maria Pia Morelli, (unknown), Ji Yuan Wu, Alexey V. Sorokin, Bahar Salimian Rizi, Christopher A. Bristow, Feng Tian, Susan Airhart, Mingshan Cheng, Bradley M. Broom, Jeffrey S. Morris, Michael J. Overman, Garth Powis, Scott Kopetz	38
7	A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients 2017 ·Supportive Care in Cancer ·David R. Fogelman, Jeffrey S. Morris, Lianchun Xiao, Moustapha Hassan, (unknown), Michael J. Overman, (unknown), Rachna T. Shroff, Gauri R. Varadhachary, Robert A. Wolff, Luis M. Vence, Anirban Maitra, Charles S. Cleeland, (unknown)	24
8	Radiomic analysis in prediction of Human Papilloma Virus status 2017 ·Clinical and Translational Radiation Oncology ·Kaixian Yu, (unknown), Yang Yu, Chao Huang, Rongjie Liu, Tengfei Li, Liuqing Yang, Jeffrey S. Morris, Veerabhadran Baladandayuthapani, Hongtu Zhu	50
9	A Randomized Controlled Trial of Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-controlled Analgesia After Major Hepatopancreatobiliary Surgery 2017 ·Annals of Surgery ·Thomas A. Aloia, Bradford J. Kim, (unknown), Juan P. Cata, Mark J. Truty, Qiuling Shi, Allen A. Holmes, José Soliz, Keyuri Popat, Thomas F. Rahlfs, Jeffrey E. Lee, Xin Shelley Wang, Jeffrey S. Morris, Vijaya Gottumukkala, Jean‐Nicolas Vauthey	61
10	Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers 2016 ·European Journal of Nuclear Medicine and Molecular Imaging ·Satoshi Takeuchi, Eric Rohren, Reham Abdel‐Wahab, Lianchun Xiao, Jeffrey S. Morris, Homer A. Macapinlac, Manal M. Hassan, Ahmed O. Kaseb	10
11	Functional CAR Models for Large Spatially Correlated Functional Datasets 2015 ·Journal of the American Statistical Association ·Zhang Li, Veerabhadran Baladandayuthapani, Hongxiao Zhu, Keith Baggerly, Tadeusz Majewski, Bogdan Czerniak, Jeffrey S. Morris	38
12	Mechanistic Contribution of Ubiquitous 15-Lipoxygenase-1 Expression Loss in Cancer Cells to Terminal Cell Differentiation Evasion 2011 ·Cancer Prevention Research ·Micheline J. Moussalli, Yuanqing Wu, Xiangsheng Zuo, (unknown), Ignacio I. Wistuba, Maria Gabriela Raso, Jeffrey S. Morris, Jessica L. Bowser, John D. Minna, Reuben Lotan, Imad Shureiqi	37
13	Profiling Lipoxygenase Metabolism in Specific Steps of Colorectal Tumorigenesis 2010 ·Cancer Prevention Research ·Imad Shureiqi, Dongning Chen, R. Sue Day, Xiangsheng Zuo, (unknown), William A. Ross, Rhonda A. Cole, (unknown), Jeffrey S. Morris, Lianchun Xiao, Robert A. Newman, Peiying Yang, Scott M. Lippman	46
14	Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization–Based Case-Control Study 2010 ·Clinical Cancer Research ·Ruth L. Katz, (unknown), Abha Khanna, (unknown), Tanweer M. Zaidi, Matthew Krebs, Nancy P. Caraway, Hua-Zhong Zhang, Feng Jiang, Margaret R. Spitz, David P. Blowers, Carlos A. Jiménez, Reza J. Mehran, Stephen G. Swisher, Jack A. Roth, Jeffrey S. Morris, Carol J. Etzel, Randa El‐Zein	37
15	Exploring the Association Between Elevated Body Mass Index and Barrett's Esophagus: A Systematic Review and Meta-Analysis 2009 ·The Annals of Thoracic Surgery ·Paresh Kamat, Sijin Wen, Jeffrey S. Morris, Sharmila Anandasabapathy	60
16	Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia 2007 ·Cancer ·Sharmila Anandasabapathy, (unknown), Marta Davila, Caimiao Wei, Jeffrey S. Morris, Robert S. Bresalier	35
17	Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma 2007 ·Cancer ·Melanie B. Thomas, Romil Chadha, Katrina Y. Glover, Xuemei Wang, Jeffrey S. Morris, Thomas D. Brown, Asif Rashid, Janet Dancey, James L. Abbruzzese	235
18	A comprehensive approach to the analysis of MALDI-TOF proteomics spectra from serum samples. 2003 ·PROTEOMICS ·Keith Baggerly, Jeffrey S. Morris, Jing Wang, David Gold, Lianchun Xiao, Kevin R. Coombes	10
19	Concordant CpG Island Methylation in Hyperplastic Polyposis 2002 ·American Journal Of Pathology ·Annie On-On Chan, Jean‐Pierre J. Issa, Jeffrey S. Morris, Stanley R. Hamilton, Asif Rashid	150
20	Hacia una economía política radical 1977 ·(unknown), (unknown), Jeffrey S. Morris, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact